Navigation Links
CT Corsearch Announces Trademark Search Capabilities for the U.S. Pharmaceutical Market
Date:3/15/2010

NEW YORK, March 15 /PRNewswire/ -- CT Corsearch, part of CT, a Wolters Kluwer business and the premier provider of clearance and protection solutions for trademark and brand professionals, today announced the availability of its new comprehensive trademark search capabilities designed specifically for the specialized needs of the pharmaceutical industry.

Pharmaceutical trademarks are unique in that brands and product names must be cleared with both the U.S. Food and Drug Administration (FDA) and the U.S. Patent and Trademark Office (USPTO). Each year, the FDA rejects about one-third of the approximately 400 brand names it reviews.

A trademarked name must be dissimilar to other existing names that could cause confusion, which is standard for trademark clearance, and also avoid consumer confusion by ensuring it is not similar to the name of a pre-existing drug or device in the look, sound when spoken and appearance when written.

The new CT Corsearch pharmaceutical trademark search combines key components in the clearance process that cover both standard trademark clearance and name safety components. The result is a big step forward in pharmaceutical clearance that incorporates the FDA's Phonetic Orthographic Computer Analysis (POCA) and summarizes unwieldy name safety data like Adverse Event Reporting System (AERS), Vaccine Adverse Event Reporting System (VAERS) into an easy-to-review summary format and overall, synthesizes name safety into the clearance process.

"Branding is a complex and potentially game-changing task for the pharmaceutical industry, where a particular name can generate millions and even billions of dollars in annual sales," said Stephen Anderson, manager of content development for CT Corsearch.  "Our new pharmaceutical trademark search addresses the two-pronged search capabilities required to help these companies be successful in clearing compelling brand names and identities quickly and effectively, so that they can focus on the task of bringing their products to market."

Key features of CT Corsearch's pharmaceutical search include:

  • A jurisdictional overview, summarizing where marks are cited across jurisdictions in chart form;
  • Functions to provide users with the ability to view identical marks across all sources searched;
  • A summary pharmaceutical information box, showing safety information about a mark;
  • Name safety, providing detail from Prescription Drug User Fee Act 4 sources, including: Orange Book, Drugs@FDA, AERS, VAERS, USAN Names and Stems and Pharma In-Use; and
  • The industry's first full integration of the FDA's POCA across sources and including POCA rankings.

"The pharmaceutical search adds a wealth of information that flags where there are real potential issues," said Susan Upton Douglass a partner at Fross, Zelnick, Lehrman & Zissu. "It was amazing to see all of these resources brought together in such an organized and useful way. This enhanced search report is really cutting edge, making the other products now obsolete."

About CT Corsearch

CT Corsearch provides high-quality, intuitive tools and expertise that trademark professionals need to effectively manage the trademark screening, search review and watching processes.  Its highly trained researchers and customer-designed tools enable the company to offer the premier solutions in the industry.  For more information, please visit www.ctcorsearch.com.  

CT, a Wolters Kluwer business, provides the tools to help legal and financial professionals manage risk on many levels.  From managing corporate compliance to legal department performance; trademark protection to matter management; electronic data discovery to preparing cases for litigation, CT has the right solution to meet a host of needs.  CT is based in New York City.  For more information, please visit www.ctlegalsolutions.com.

About Wolters Kluwer

Wolters Kluwer is a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer's leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer has 2009 annual revenues of euro 3.4 billion ($4.8 billion/3.0 billion pounds Sterling), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.

Visit our website, YouTube or follow @Wolters_Kluwer on Twitter for more information about our customers, market positions, brands, and organization.

SOURCE CT Corsearch

Back to top

RELATED LINKS
http://www.ctcorsearch.com

'/>"/>

SOURCE CT Corsearch
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):